Reuters logo
BRIEF-Asterias Biotherapeutics opens additional clinical site for AST-OPC1 SCiStar study
2017年8月23日 / 上午11点10分 / 3 个月前

BRIEF-Asterias Biotherapeutics opens additional clinical site for AST-OPC1 SCiStar study

Aug 23 (Reuters) - Asterias Biotherapeutics Inc

* Asterias Biotherapeutics opens additional clinical site for AST-OPC1 SCiStar study

* Asterias Biotherapeutics Inc- ‍there are now nine clinical sites enrolling patients in study​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below